11.93
price up icon0.55%   0.065
 
loading

Mbx Biosciences Inc Borsa (MBX) Ultime notizie

pulisher
09:06 AM

MBX Biosciences, Inc. Announces Departure of Carl L. Gordon from the Company's Board of Directors, Effective June 5, 2025 - marketscreener.com

09:06 AM
pulisher
08:33 AM

mbx biosciences announces board changes and director elections - Investing.com

08:33 AM
pulisher
08:18 AM

MBX Biosciences Elects Directors at Annual Meeting - TipRanks

08:18 AM
pulisher
Jun 04, 2025

Deutsche Bank AG Buys New Position in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases Shares of 6,335 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha

May 31, 2025
pulisher
May 30, 2025

MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 30, 2025
pulisher
May 28, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLC - Defense World

May 28, 2025
pulisher
May 27, 2025

Northern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 27, 2025
pulisher
May 20, 2025

MBX Biosciences to Participate in June Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

MBX Biosciences Showcases Precision Peptide Pipeline at Two Major Healthcare Conferences This June - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Citadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 19, 2025
pulisher
May 15, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

MBX Biosciences Reports Q1 2025 Financial Progress - TipRanks

May 14, 2025
pulisher
May 13, 2025

MBX Biosciences, Inc.: Strong Buy Rating Amid Promising Phase II Data and Robust Financial Position - TipRanks

May 13, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Stifel maintains MBX Biosciences stock Buy rating, $40 target - Investing.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Purchases Shares of 5,844 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

May 12, 2025
pulisher
May 09, 2025

Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com

May 09, 2025
pulisher
May 05, 2025

MBX Biosciences Up 28%, Insider Buyers Are Up 19% - simplywall.st

May 05, 2025
pulisher
May 05, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 05, 2025
pulisher
Apr 27, 2025

MBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 23, 2025

JMP maintains MBX Biosciences stock $38 target, upbeat on trial data - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

MBX Biosciences Reveals Growth Strategy at Citizens and RBC Healthcare Conferences: Key Updates Coming - Stock Titan

Apr 22, 2025
pulisher
Apr 16, 2025

5,593 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Corebridge Financial Inc. - Defense World

Apr 16, 2025
pulisher
Apr 13, 2025

25,000 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Norges Bank - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives $37.40 Consensus Price Target from Brokerages - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

MBX Biosciences initiated at Market Outperform by Citizens - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

Director Makes Bold Move with Major MBX Biosciences Stock Purchase - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

JMP Securities Initiates Coverage of MBX Biosciences (MBX) with Market Outperform Recommendation - Nasdaq

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences: Innovative PEP Platform and Promising Pipeline Drive Buy Rating - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Bio stock initiated at Market Outperform by Citizens (MBX) - Seeking Alpha

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences director Pescovitz buys $45,311 in stock By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences director Pescovitz buys $45,311 in stock - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

MBX Biosciences initiated with an Outperform at Citizens JMP - TipRanks

Apr 10, 2025
pulisher
Apr 07, 2025

MBX Biosciences adds biotech veteran to board By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences adds biotech veteran to board - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences Appoints Steve Hoerter to Board - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors - GlobeNewswire

Apr 07, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Invests $1.72 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Buys Shares of 23,914 MBX Biosciences, Inc. (NYSE:MBX) - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 26, 2025
$1.15
price up icon 1.30%
$584.68
price up icon 0.75%
$308.75
price up icon 1.19%
$37.33
price up icon 2.30%
$4.68
price down icon 3.35%
$492.00
price up icon 1.78%
Capitalizzazione:     |  Volume (24 ore):